Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takashi Ichimura
Observed names:
Ichimura Takashi,
Ichimura, Takashi,
T. Ichimura
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Ministry of Health Labour and Welfare,
Government of Japan,
Osaka City University,
Saitama International Medical Center,
The Cancer Institute Hospital,
Saitama Red Cross Hospital,
Japanese Foundation For Cancer Research,
The University of Tokyo,
Saitama Medical University
show all 9
ORCID:
0000-0003-0231-6511
Observed ORCID:
0000-0003-0231-6511
OpenAlex ID:
A5014800720
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
2014
·
Miwako Kakiuchi
, Takashi Nishizawa
, et al.
·
Nature Genetics
·
562
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
2018
·
Takeru Wakatsuki
, Noriko Yamamoto
, et al.
·
Journal of Gastroenterology
·
118
PDF
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
2018
·
Hiroki Osumi
, Eiji Shinozaki
, et al.
·
Cancer Medicine
·
87
PDF
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
2018
·
Shusuke Yagi
, Takeru Wakatsuki
, et al.
·
Gastric Cancer
·
81
PDF
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival
2020
·
Yumiko Ota
, Daisuke Takahari
, et al.
·
Cancer Chemotherapy and Pharmacology
·
73
Prognostic Significance of CD204-Positive Macrophages in Upper Urinary Tract Cancer
2014
·
Takashi Ichimura
, Teppei Morikawa
, et al.
·
Annals of Surgical Oncology
·
46
Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus–associated gastric cancer: a clinicopathologic study with digital image analysis
2016
·
Takashi Ichimura
, Hiroyuki Abe
, et al.
·
Human Pathology
·
37
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
2019
·
Takeshi Suzuki
, Akihiko Okamura
, et al.
·
Annals of Surgical Oncology
·
34
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
2017
·
Izuma Nakayama
, Eiji Shinozaki
, et al.
·
BMC Cancer
·
26
PDF
Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer
2019
·
Hiroki Osumi
, Eiji Shinozaki
, et al.
·
International Journal of Cancer
·
25
PDF
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer
2017
·
Hiroki Osumi
, Daisuke Takahari
, et al.
·
Gastric Cancer
·
24
PDF
CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells
2018
·
Hiroyuki Abe
, Ruri Saito
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
21
Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
2017
·
A. Okamura
, M. Watanabe
, et al.
·
Diseases of the Esophagus
·
20
Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake
2018
·
Hiroki Osumi
, Daisuke Takahari
, et al.
·
OncoTargets and Therapy
·
18
PDF
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel
2018
·
Naoki Fukuda
, Daisuke Takahari
, et al.
·
Oncotarget
·
18
PDF
Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
2009
·
Mitsukuni Suenaga
, Nobuyuki Mizunuma
, et al.
·
Medical Oncology
·
16
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study
2022
·
Akie Kimura Yoshikawa
, Kensei Yamaguchi
, et al.
·
Journal for ImmunoTherapy of Cancer
·
15
PDF
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers
2021
·
Kazuo Kobayashi
, Erika Sugiyama
, et al.
·
Cancer Chemotherapy and Pharmacology
·
15
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer
2019
·
Takeshi Suzuki
, Eiji Shinozaki
, et al.
·
Cancer Chemotherapy and Pharmacology
·
14
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma
2017
·
Satoshi Murahashi
, Daisuke Takahari
, et al.
·
International Journal of Clinical Oncology
·
14
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma
2022
·
Akira Ooki
, Taroh Satoh
, et al.
·
Scientific Reports
·
13
PDF
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis
2017
·
Izuma Nakayama
, Keisho Chin
, et al.
·
International Journal of Clinical Oncology
·
13
MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma
2015
·
Naohiro Makise
, Teppei Morikawa
, et al.
·
Human Pathology
·
13
Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer—a retrospective study
2020
·
Takeshi Aoyama
, Takashi Tsunoda
, et al.
·
Journal of Chemotherapy
·
11
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
2015
·
Izuma Nakayama
, Mitsukuni Suenaga
, et al.
·
Cancer Chemotherapy and Pharmacology
·
11
Show more works
View as search
Works count:
87
Citation count:
1,430
H-index:
16
I10-index:
27
Year
Topic
Type